Ascendis Pharma Statistics

Total Valuation

ASND has a market cap or net worth of $7.63 billion. The enterprise value is $8.07 billion.

Market Cap	7.63B
Enterprise Value	8.07B

Important Dates

The next confirmed earnings date is Thursday, November 14, 2024, after market close.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

ASND has 59.76 million shares outstanding. The number of shares has increased by 1.33% in one year.

Current Share Class	n/a
Shares Outstanding	59.76M
Shares Change (YoY)	+1.33%
Shares Change (QoQ)	+0.81%
Owned by Insiders (%)	0.74%
Owned by Institutions (%)	78.08%
Float	59.32M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	21.30
Forward PS	12.71
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	23.72
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.74

Current Ratio	0.74
Quick Ratio	0.40
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.66

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-27.92%
Return on Capital (ROIC)	-47.90%
Revenue Per Employee	$387,176
Profits Per Employee	-$596,701
Employee Count	879
Asset Turnover	0.40
Inventory Turnover	0.22

Taxes

In the past 12 months, ASND has paid $9.83 million in taxes.

Income Tax	9.83M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +41.42% in the last 52 weeks. The beta is 0.65, so ASND's price volatility has been lower than the market average.

Beta (5Y)	0.65
52-Week Price Change	+41.42%
50-Day Moving Average	131.91
200-Day Moving Average	137.22
Relative Strength Index (RSI)	47.30
Average Volume (20 Days)	337,527

Short Selling Information

Short Interest	3.41M
Short Previous Month	3.23M
Short % of Shares Out	8.03%
Short % of Float	n/a
Short Ratio (days to cover)	8.50

Income Statement

In the last 12 months, ASND had revenue of $340.33 million and -$524.50 million in losses. Loss per share was -$9.24.

Revenue	340.33M
Gross Profit	291.17M
Operating Income	-378.68M
Pretax Income	-539.03M
Net Income	-524.50M
EBITDA	-372.01M
EBIT	-378.68M
Loss Per Share	-$9.24

Full Income Statement

Balance Sheet

The company has $277.18 million in cash and $720.71 million in debt, giving a net cash position of -$443.53 million or -$7.42 per share.

Cash & Cash Equivalents	277.18M
Total Debt	720.71M
Net Cash	-443.53M
Net Cash Per Share	-$7.42
Equity (Book Value)	-344.08M
Book Value Per Share	-6.00
Working Capital	-236.17M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$353.67 million and capital expenditures -$1.56 million, giving a free cash flow of -$351.98 million.

Operating Cash Flow	-353.67M
Capital Expenditures	-1.56M
Free Cash Flow	-351.98M
FCF Per Share	-$5.89

Full Cash Flow Statement

Margins

Gross margin is 85.56%, with operating and profit margins of -111.27% and -154.12%.

Gross Margin	85.56%
Operating Margin	-111.27%
Pretax Margin	-151.23%
Profit Margin	-154.12%
EBITDA Margin	-109.31%
EBIT Margin	-111.27%
FCF Margin	-129.43%

Dividends & Yields

ASND does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.33%
Shareholder Yield	-1.33%
Earnings Yield	-6.87%
FCF Yield	-4.61%

Dividend Details

Analyst Forecast

The average price target for ASND is $195.92, which is 53.46% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$195.92
Price Target Difference	53.46%
Analyst Consensus	Strong Buy
Analyst Count	13
Revenue Growth Forecast (5Y)	56.74%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASND has an Altman Z-Score of -2.6 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.6
Piotroski F-Score	4